AI Science Tracker

Discovering novel Cathepsin L inhibitors from natural products using artificial intelligence

Beijing Key Laboratory of Diabetes Research and Care, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China. · 7 Jun 2024 · chemistry

Discovery

Discovering novel Cathepsin L inhibitors from natural products using artificial intelligence

Source check: Needs source check. Not independent scientific confirmation.

Finding: Discovering novel Cathepsin L inhibitors from natural products using artificial intelligence. Screened natural products for Cathepsin L inhibitors; 150 molecules were selected for testing. 36 of 150 inhibited CTSL by more than 50 percent at 100 uM; 13 exceeded 90 percent; plumbagin and beta-lapachone were most potent. Evidence limits: Only enzyme assays and MD; cellular or in vivo effects and hit-rate against a random baseline not assessed. Reviewed from Europe PMC abstract only.

Technology: Deep learning model with molecular docking

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Screened natural products for Cathepsin L inhibitors; 150 molecules were selected for testing.
Test and result
36 of 150 inhibited CTSL by more than 50 percent at 100 uM; 13 exceeded 90 percent; plumbagin and beta-lapachone were most potent.
Limitation / still unknown
Only enzyme assays and MD; cellular or in vivo effects and hit-rate against a random baseline not assessed.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/39006920

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse chemistry discoveries.